Community Research and Development Information Service - CORDIS

H2020

EBOVAC2

Project ID: 115861
Funded under

Development of a Prophylactic Ebola Vaccine Using an Heterologous Prime-Boost Regimen: Phase II

From 2014-12-01 to 2019-11-30, ongoing project

Project details

Total cost:

EUR 50 710 893

EU contribution:

EUR 22 790 820

Coordinated in:

France

Call for proposal:

H2020-JTI-IMI2-2014-02-single-stageSee other projects for this call

Funding scheme:

IMI2-RIA - Research and Innovation action

Objective

Coordinator

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France

EU contribution: EUR 14 879 129


RUE DE TOLBIAC 101
75654 PARIS
France
Activity type: Research Organisations

Contact the organisation

Participants

CRUCELL HOLLAND B.V.
Netherlands

EU contribution: EUR 0


ARCHIMEDESWEG 4
2333 CN LEIDEN
Netherlands
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE
United Kingdom

EU contribution: EUR 463 876


KEPPEL STREET
WC1E7HT LONDON
United Kingdom
Activity type: Higher or Secondary Education Establishments

Contact the organisation

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

EU contribution: EUR 2 001 315


University Offices, Wellington Square
OX1 2JD OXFORD
United Kingdom
Activity type: Higher or Secondary Education Establishments

Contact the organisation

Centre Muraz
Burkina Faso

EU contribution: EUR 5 075 000


Avenue Mamadou Konate
NA BOBO-DIOULASSO
Burkina Faso
Activity type: Research Organisations

Contact the organisation

INSERM - TRANSFERT SA
France

EU contribution: EUR 371 500


Rue Watt 7
75013 PARIS
France
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top